bloating after semaglutide shot The GLP-1 Bulge: Is a Normal Side Effect? Semaglutide Burping: Why It Happens

Recent Findings Retatrutide is the first triple agonist (acting on GLP-1/GIP/glucagon receptors) with published phase 2 data in people with obesity as well as in people with T2D

We also observed no changes in motor neuron counts or glial activation in lumbar spinal cords of liraglutide treated mice compared to vehicle dosed mice

A US-based study in people with #T2DM found that GLP-1 agonists not only do NOT increase the risk of pancreatitisbut are actually associated with a lower lifetime risk compared to non-users

Archives of physiology and biochemistry, 130(6), 678685

it is a metabolic intervention that must be guided by functional and body composition outcomes

I believe this is where more structured guidance around GLP-1 therapy is needed moving forward